Search research articles
Contact Us
Filters
Showing results (121-130 of 192) with videos related to
Page
of 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2010
Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
Valérie Boige, Jean Mendiboure, Jean-Pierre Pignon, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
The EMBO Journal
|
July 16, 2019
ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas
Fotine Libanje, Joel Raingeaud, Rui Luan, et al.
Neuroendocrinology
|
May 27, 2016
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study
Amandine Berdelou, Valérie Boige, Julia Arfi-Rouche, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 4, 2021
Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group
Clémence Breton, Antoine Meyer, David Malka, et al.
Gastroenterologie Clinique Et Biologique
|
November 1, 2006
[What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?]
Jean-Louis Legoux, Laurent Bedenne, Jean-François Seitz, et al.
Familial Cancer
|
September 27, 2013
Diversity of the clinical presentation of the MMR gene biallelic mutations
Gaëlle Bougeard, Laurence Olivier-Faivre, Stéphanie Baert-Desurmont, et al.
Clinical Colorectal Cancer
|
January 12, 2016
Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer
Alexandra Lapeyre-Prost, Marine Hug de Larauze, Benoist Chibaudel, et al.
Endocrine-Related Cancer
|
July 13, 2013
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Fritz-Line Vélayoudom-Céphise, Pierre Duvillard, Lydia Foucan, et al.
Neuroendocrinology
|
August 4, 2021
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors
Paul Girot, Eric Baudin, Hélène Senellart, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 192) with videos related to
Sort By:
Page
of 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 14, 2010
Pharmacogenetic assessment of toxicity and outcome in patients with metastatic colorectal cancer treated with LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05
Valérie Boige, Jean Mendiboure, Jean-Pierre Pignon, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
The EMBO Journal
|
July 16, 2019
ROCK2 inhibition triggers the collective invasion of colorectal adenocarcinomas
Fotine Libanje, Joel Raingeaud, Rui Luan, et al.
Neuroendocrinology
|
May 27, 2016
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective Study
Amandine Berdelou, Valérie Boige, Julia Arfi-Rouche, et al.
Clinics and Research in Hepatology and Gastroenterology
|
March 4, 2021
Local treatment of pancreatic cancer metastases: A multicenter French study of the AGEO group
Clémence Breton, Antoine Meyer, David Malka, et al.
Gastroenterologie Clinique Et Biologique
|
November 1, 2006
[What changes were made in the National Thesaurus of Gastrointestinal Cancer in 2005?]
Jean-Louis Legoux, Laurent Bedenne, Jean-François Seitz, et al.
Familial Cancer
|
September 27, 2013
Diversity of the clinical presentation of the MMR gene biallelic mutations
Gaëlle Bougeard, Laurence Olivier-Faivre, Stéphanie Baert-Desurmont, et al.
Clinical Colorectal Cancer
|
January 12, 2016
Feasibility of Capecitabine and Oxaliplatin Combination Chemotherapy Without Central Venous Access Device in Patients With Stage III Colorectal Cancer
Alexandra Lapeyre-Prost, Marine Hug de Larauze, Benoist Chibaudel, et al.
Endocrine-Related Cancer
|
July 13, 2013
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Fritz-Line Vélayoudom-Céphise, Pierre Duvillard, Lydia Foucan, et al.
Neuroendocrinology
|
August 4, 2021
Oxaliplatin and 5-Fluorouracil in Advanced Well-Differentiated Digestive Neuroendocrine Tumors: A Multicenter National Retrospective Study from the French Group of Endocrine Tumors
Paul Girot, Eric Baudin, Hélène Senellart, et al.
Page
of 20